Taysha Gene Therapies, Inc. — All Filings
377 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
144/A
3
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DRS
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| EFFECT | — | 9999999995-23-002613 | Sep 8, 2023 | — |
| CORRESP | — | 0001193125-23-230112 | Sep 7, 2023 | — |
| UPLOAD | — | 0000000000-23-009862 | Sep 6, 2023 | — |
| S-3 | S-3 | 0001193125-23-224918 | Aug 30, 2023 | — |
| 8-K | 8-K | 0001193125-23-222964 | Aug 29, 2023 | Aug 28, 2023 |
| SC 13G | SC 13G | 0001104659-23-096003 | Aug 28, 2023 | — |
| SC 13G | SC 13G | 0001193125-23-221528 | Aug 25, 2023 | — |
| SC 13G | SC 13G | 0001104659-23-095393 | Aug 25, 2023 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-23-047323 | Aug 25, 2023 | Aug 24, 2023 |
| D | — | 0001231919-23-000063 | Aug 25, 2023 | — |
| 8-K | 8-K | 0001193125-23-219580 | Aug 24, 2023 | — |
| 144 | — | 0001968582-23-000435 | Aug 24, 2023 | — |
| SC 13D/A | SC 13D/A | 0001193125-23-216942 | Aug 21, 2023 | — |
| SC 13D/A | SC 13D/A | 0001193125-23-216053 | Aug 18, 2023 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-23-046154 | Aug 16, 2023 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-23-046152 | Aug 16, 2023 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-23-046150 | Aug 16, 2023 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-23-046148 | Aug 16, 2023 | — |
| 8-K | 8-K | 0001193125-23-211456 | Aug 14, 2023 | — |
| 10-Q | 10-Q | 0000950170-23-042089 | Aug 14, 2023 | Jun 30, 2023 |
| 8-K | 8-K | 0001193125-23-203836 | Aug 4, 2023 | Aug 3, 2023 |
| 8-K | 8-K | 0001193125-23-198580 | Jul 31, 2023 | — |
| 4 | 4 | 0000950170-23-032986 | Jul 14, 2023 | Jul 12, 2023 |
| 8-K | 8-K | 0001193125-23-176864 | Jun 28, 2023 | — |
| 4 | FORM 4 SUBMISSION | 0000899243-23-016491 | Jun 26, 2023 | Jun 22, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-039733 | Jun 26, 2023 | Jun 22, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-039732 | Jun 26, 2023 | Jun 22, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-039731 | Jun 26, 2023 | Jun 22, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-039730 | Jun 26, 2023 | Jun 22, 2023 |
| 3 | FORM 3 SUBMISSION | 0001209191-23-039728 | Jun 26, 2023 | Jun 22, 2023 |
| 8-K | 8-K | 0001193125-23-173983 | Jun 23, 2023 | Jun 22, 2023 |
| 4 | FORM 4 SUBMISSION | 0000899243-23-016232 | Jun 22, 2023 | Jun 20, 2023 |
| 8-K | 8-K | 0001193125-23-172678 | Jun 22, 2023 | Jun 20, 2023 |
| 144 | — | 0001968582-23-000263 | Jun 20, 2023 | — |
| 144/A | — | 0001968582-23-000266 | Jun 20, 2023 | — |
| 8-K | 8-K | 0001193125-23-161593 | Jun 6, 2023 | May 31, 2023 |
| 8-K | 8-K | 0001193125-23-160348 | Jun 5, 2023 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-23-033681 | Jun 2, 2023 | May 31, 2023 |
| 144 | — | 0001231919-23-000038 | Jun 1, 2023 | — |
| 144 | — | 0001231919-23-000039 | Jun 1, 2023 | — |
| 8-K | 8-K | 0001193125-23-148827 | May 19, 2023 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-23-030661 | May 18, 2023 | May 16, 2023 |
| 8-K | 8-K | 0001193125-23-145197 | May 15, 2023 | May 11, 2023 |
| 144 | — | 0001231919-23-000029 | May 11, 2023 | — |
| 10-Q | 10-Q | 0000950170-23-021333 | May 11, 2023 | Mar 31, 2023 |
| DEF 14A | DEF 14A | 0001193125-23-138221 | May 8, 2023 | Jun 22, 2023 |
| DEFA14A | DEFA14A | 0001193125-23-138223 | May 8, 2023 | — |
| ARS | ARS | 0001193125-23-138235 | May 8, 2023 | Dec 31, 2022 |
| 424B3 | 424B3 | 0001193125-23-135884 | May 4, 2023 | — |
| EFFECT | — | 9999999995-23-001202 | May 1, 2023 | — |